Article Information
History
- September 10, 2022.
Article Versions
- You are currently viewing Version 1 of this article (September 10, 2022 - 00:20).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Daniel T. D. Jones1,#,
- Andrew N. Dates1,
- Shaun D. Rawson1,
- Maggie M. Burruss1,
- Colin H. Lipper1 and
- Stephen C. Blacklow1,2,*,#
- 1Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA
- 2Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA
- ↵#Correspondence: stephen_blacklow{at}hms.harvard.edu and daniel_jones{at}hms.harvard.edu.
Posted September 10, 2022.
Tethered agonist activated ADGRF1 structure reveals molecular preference for Gαq signalling
